24th Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP)

Publication Date: 08.03.2019
Cardiovasc Med. 2019;22:w02020

Lugano–Switzerland, Thursday, May 9th and Friday, May 10th 2019

Organized in collaboration with the Working Group on Cardiovascular Pharmacotherapy (European Society of Cardiology), the Swiss Society of Cardiology (SSC), the Swiss Atherosclerosis Association, and the French Society of Cardiology

Programme and inscription:

Preliminary programme

Course Directors: Prof Augusto Gallino, Bellinzona CH, Prof Juan Carlos Kaski, London GB, Prof Alexandre Fredenrich, Bellinzona CH/Nice FR, Prof Heinz Drexel, Feldkirch AT

Thursday, May 9th 2019

08.10–08.15: Brief opening of the meeting

08.15–09.35: World epidemics – Joint Session with ESC Working Group on Cardiovascular Pharmacotherapy

09.35–10.35: A changing paradigm in management of dyslipidemia

10.35–11.05 Coffee break

11.05–12.20: Anti-inflammatory treatment in coronary artery disease with participation of P. Libby

12.05–12.30: Key lecture: Cardiovascular pharmacotherapy in the elderly

12.30–13.30: PCSK9 inhibitors: How to bridge from high clinical value to access for patients?

12.30–13.30 Lunch

13.30–14.20: Medical vs invasive treatment strategies in stable coronary artery disease: debate session

14.20–15.20: Emerging indications for new oral anticoagulation in stable coronary artery disease

15.20‒15.50: Coffee break

15.50–16.35: Antithrombotic treatment in acute coronary artery disease in the world of emerging stents

16.35–17.30: PCSK-9 inhibition: Insights from the ODYSSEY OUTCOMES Trial
17.30–18.00: Distinguished Eugene Braunwald Lecture given by Eugene Braunwald

18.00–18.30: Neufeld Lecture given by / and awarded to Salim Yusuf

Friday, May 10th 2019

08.15–09.30: Atrial fibrillation

09.30–10.10: Chronic heart failure: a paradigm shift

10.40–11.15: Key lecture: Acute heart failure

11.15–11.45: State of the art lecture: Pharmacotherapy of the future: From Molecules to genetic tools

11.45–12.45: New antidiabetic drugs improve cardiovascular morbidity and mortality in patients with coronary artery disease and diabetes

12.45–13.15: Key lecture: Cardiovascular effects of incretin-based therapies: lessons from the trials testing GLP1 RAs

13.15–14.00: The emerging role of PCSK9 inhibitors after ACS

13.15‒14.15: Lunch

14.15–15.15: Arterial hypertension

15.15–15.40: Aspirin in primary prevention: a paradigm change?

15.40–16.20: Ventricular and atrial remodeling ‒ the road to heart failure and stroke: future approaches (joint session with the French Society of Cardiology)

16.20–16.45: ISCP awards

16.45: End of the Meeting

Verpassen Sie keinen Artikel!